Stocks · News reference
Lunai Bioworks Inc. received a notice from Nasdaq regarding non-compliance with minimum stockholders' equity requirements and subsequently announced its intention to voluntarily delist and deregister.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-10-23 AccNo: 0001731122-26-001362 Size: 212 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Alcoa shares rose after Q3 earnings beat estimates; Rubico and others surged, while Nuburu, Jaguar Health and other stocks fell premarket.
On October 9, 2026, Lunai Bioworks, Inc. (the "Company") submitted a formal request to The Nasdaq Stock Market LLC ("Nasdaq") asking Nasdaq to immediately suspend trading in the Company’s common stock to